Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.

MLA

Roos, Alison, et al. “Identification of Aurintricarboxylic Acid as a Selective Inhibitor of the TWEAK-Fn14 Signaling Pathway in Glioblastoma Cells.” Oncotarget, vol. 8, no. 7, Feb. 2017, pp. 12234–46. EBSCOhost, https://doi.org/10.18632/oncotarget.14685.

APA

Roos, A., Dhruv, H. D., Mathews, I. T., Inge, L. J., Tuncali, S., Hartman, L. K., Chow, D., Millard, N., Yin, H. H., Kloss, J., Loftus, J. C., Winkles, J. A., Berens, M. E., & Tran, N. L. (2017). Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Oncotarget, 8(7), 12234–12246. https://doi.org/10.18632/oncotarget.14685

Chicago

Roos, Alison, Harshil D Dhruv, Ian T Mathews, Landon J Inge, Serdar Tuncali, Lauren K Hartman, Donald Chow, et al. 2017. “Identification of Aurintricarboxylic Acid as a Selective Inhibitor of the TWEAK-Fn14 Signaling Pathway in Glioblastoma Cells.” Oncotarget 8 (7): 12234–46. doi:10.18632/oncotarget.14685.